ClinicalTrials.gg
Status unknownNCT06698315Updated Nov 20, 2024

Evidence-based Approach to Reduce Falls in Adult Patients

An observational study in Falls with Injuries, sponsored by Methodist Health System. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-20.

Sponsored by Methodist Health System · Observational

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The project aims to promote patient safety and quality care by reducing preventable falls and falls with injuries using an evidence-based solution.

Read the detailed description

The project aims to promote patient safety and quality care by reducing preventable falls and falls with injuries using an evidence-based solution: the Fall Tailoring Interventions for Patient Safety (TIPS) intervention. The three objectives include: (a) developing personalized fall prevention interventions for high-risk patients, (b) engaging patients and families in fall prevention initiatives, and (c) promoting effective communication among teams using a bedside visual tool.

02

Conditions studied

  • Falls with Injuries
03

In context

Lead sponsor

Methodist Health System is the lead sponsor of 170 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with psychiatric conditions and cognitive impairments will be excluded from the project. This assessment is routine.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (≥18 years) inpatients admitted for various medical-surgical conditions in 3 Medical unit at MRMC. All patients will be included in the project except those diagnosed with psychiatric conditions and cognitive impairments.

Exclusion criteria

Exclusion Criteria:

  • Patients with psychiatric conditions and cognitive impairments will be excluded from the project. This assessment is routine.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Interventions

  • OtherObservation

    Medical Records Chart Review

06

What researchers measure

Primary outcomes

  1. Determine if the Fall TIPS initiative is effective at reducing falls at MRMC.

    Data will be collected from Verge and EPIC reports. To ensure intervention effectiveness, monitoring will be done through chart audits and staff reporting. EPIC slicer dicer generates customized reports, enhancing EHR effectiveness (Ayaad et al., 2022).

    Time frame: through study completion, up to 18 months

07

Study locations

1 of 1 sites recruiting
  • Methodist Dallas Medical Center- Clinical Research Institute
    Dallas, Texas 75203, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2024 (actual). Primary completion is estimated for Jul 2025, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 18, 2024
First posted
Nov 20, 2024
StartActual
Jul 23, 2024
Primary completionEst.
Jul 2025
CompletionEst.
Jul 2025
Last update
Nov 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06698315
Responsible party
Sponsor
First posted
Nov 20, 2024
Start date
Jul 23, 2024
Primary completion
Jul 2025 (estimated)
Completion
Jul 2025 (estimated)
Last update
Nov 20, 2024

Study contacts

Jeff Wilson, BS
Contact
JeffreyWilson@mhd.com
2149471279
Colette Ngo Ndjom, MS
Contact
ColetteNgoNdjom@mhd.com
(214) 947-1289
ELIZABETH D AARON, MSN
principal investigator · METHODIST RICHARDSON MEDICAL CENTER

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion